Iofina (IOF) Competitors

Iofina logo
GBX 53 0.00 (0.00%)
As of 08:33 AM Eastern

IOF vs. ESNT, ZTF, TET, SYNT, and HDD

Should you buy Iofina stock or one of its competitors? MarketBeat compares Iofina with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Iofina include Essentra (ESNT), Zotefoams (ZTF), Treatt (TET), Synthomer (SYNT), and Hardide (HDD). These companies are all part of the "specialty chemicals" industry.

How does Iofina compare to Essentra?

Essentra (LON:ESNT) and Iofina (LON:IOF) are both small-cap basic materials companies, but which is the better stock? We will compare the two businesses based on the strength of their profitability, dividends, institutional ownership, risk, valuation, media sentiment, earnings and analyst recommendations.

In the previous week, Essentra and Essentra both had 1 articles in the media. Iofina's average media sentiment score of 0.49 beat Essentra's score of 0.00 indicating that Iofina is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Essentra
0 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Iofina
0 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

69.5% of Essentra shares are held by institutional investors. Comparatively, 1.5% of Iofina shares are held by institutional investors. 0.5% of Essentra shares are held by insiders. Comparatively, 13.4% of Iofina shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Essentra presently has a consensus target price of GBX 150, indicating a potential upside of 83.15%. Iofina has a consensus target price of GBX 60, indicating a potential upside of 13.21%. Given Essentra's higher probable upside, equities analysts clearly believe Essentra is more favorable than Iofina.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Essentra
0 Sell rating(s)
1 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.80
Iofina
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00

Iofina has lower revenue, but higher earnings than Essentra. Iofina is trading at a lower price-to-earnings ratio than Essentra, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Essentra£302M0.76£3.50M£0.70117.00
Iofina£66.52M1.53£4.28M£4.0013.25

Iofina has a net margin of 11.84% compared to Essentra's net margin of 0.70%. Iofina's return on equity of 14.89% beat Essentra's return on equity.

Company Net Margins Return on Equity Return on Assets
Essentra0.70% 0.79% 1.74%
Iofina 11.84%14.89%5.18%

Essentra has a beta of 0.822, meaning that its share price is 18% less volatile than the broader market. Comparatively, Iofina has a beta of 0.53, meaning that its share price is 47% less volatile than the broader market.

Summary

Iofina beats Essentra on 9 of the 15 factors compared between the two stocks.

How does Iofina compare to Zotefoams?

Iofina (LON:IOF) and Zotefoams (LON:ZTF) are both small-cap basic materials companies, but which is the superior business? We will compare the two companies based on the strength of their risk, valuation, media sentiment, analyst recommendations, dividends, earnings, institutional ownership and profitability.

Iofina has a beta of 0.53, suggesting that its share price is 47% less volatile than the broader market. Comparatively, Zotefoams has a beta of 1.24, suggesting that its share price is 24% more volatile than the broader market.

Zotefoams has higher revenue and earnings than Iofina. Zotefoams is trading at a lower price-to-earnings ratio than Iofina, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Iofina£66.52M1.53£4.28M£4.0013.25
Zotefoams£158.49M1.31£9.80M£44.879.42

1.5% of Iofina shares are held by institutional investors. Comparatively, 29.6% of Zotefoams shares are held by institutional investors. 13.4% of Iofina shares are held by company insiders. Comparatively, 4.5% of Zotefoams shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

In the previous week, Iofina and Iofina both had 1 articles in the media. Iofina's average media sentiment score of 0.49 beat Zotefoams' score of 0.00 indicating that Iofina is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Iofina
0 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Zotefoams
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Iofina presently has a consensus price target of GBX 60, indicating a potential upside of 13.21%. Zotefoams has a consensus price target of GBX 605, indicating a potential upside of 43.21%. Given Zotefoams' higher probable upside, analysts clearly believe Zotefoams is more favorable than Iofina.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Iofina
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00
Zotefoams
0 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
3.00

Zotefoams has a net margin of 14.28% compared to Iofina's net margin of 11.84%. Zotefoams' return on equity of 18.25% beat Iofina's return on equity.

Company Net Margins Return on Equity Return on Assets
Iofina11.84% 14.89% 5.18%
Zotefoams 14.28%18.25%5.48%

Summary

Zotefoams beats Iofina on 10 of the 14 factors compared between the two stocks.

How does Iofina compare to Treatt?

Iofina (LON:IOF) and Treatt (LON:TET) are both small-cap basic materials companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, risk, analyst recommendations, valuation, profitability, earnings, dividends and media sentiment.

1.5% of Iofina shares are owned by institutional investors. Comparatively, 17.5% of Treatt shares are owned by institutional investors. 13.4% of Iofina shares are owned by insiders. Comparatively, 4.1% of Treatt shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Treatt has higher revenue and earnings than Iofina. Iofina is trading at a lower price-to-earnings ratio than Treatt, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Iofina£66.52M1.53£4.28M£4.0013.25
Treatt£128.29M1.40£11.22M£7.2242.04

In the previous week, Iofina had 1 more articles in the media than Treatt. MarketBeat recorded 1 mentions for Iofina and 0 mentions for Treatt. Iofina's average media sentiment score of 0.49 beat Treatt's score of 0.25 indicating that Iofina is being referred to more favorably in the media.

Company Overall Sentiment
Iofina Neutral
Treatt Neutral

Iofina has a net margin of 11.84% compared to Treatt's net margin of 3.40%. Iofina's return on equity of 14.89% beat Treatt's return on equity.

Company Net Margins Return on Equity Return on Assets
Iofina11.84% 14.89% 5.18%
Treatt 3.40%3.22%6.72%

Iofina currently has a consensus price target of GBX 60, suggesting a potential upside of 13.21%. Treatt has a consensus price target of GBX 248.33, suggesting a potential downside of 18.18%. Given Iofina's stronger consensus rating and higher possible upside, analysts clearly believe Iofina is more favorable than Treatt.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Iofina
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00
Treatt
0 Sell rating(s)
2 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.33

Iofina has a beta of 0.53, indicating that its share price is 47% less volatile than the broader market. Comparatively, Treatt has a beta of 0.907, indicating that its share price is 9% less volatile than the broader market.

Summary

Iofina beats Treatt on 8 of the 15 factors compared between the two stocks.

How does Iofina compare to Synthomer?

Synthomer (LON:SYNT) and Iofina (LON:IOF) are both small-cap basic materials companies, but which is the better stock? We will compare the two companies based on the strength of their analyst recommendations, profitability, media sentiment, institutional ownership, risk, valuation, earnings and dividends.

Synthomer presently has a consensus target price of GBX 86.75, suggesting a potential downside of 7.72%. Iofina has a consensus target price of GBX 60, suggesting a potential upside of 13.21%. Given Iofina's stronger consensus rating and higher probable upside, analysts clearly believe Iofina is more favorable than Synthomer.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Synthomer
0 Sell rating(s)
4 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00
Iofina
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00

In the previous week, Synthomer had 5 more articles in the media than Iofina. MarketBeat recorded 6 mentions for Synthomer and 1 mentions for Iofina. Iofina's average media sentiment score of 0.49 beat Synthomer's score of 0.38 indicating that Iofina is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Synthomer
2 Very Positive mention(s)
2 Positive mention(s)
1 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral
Iofina
0 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Iofina has a net margin of 11.84% compared to Synthomer's net margin of -9.03%. Iofina's return on equity of 14.89% beat Synthomer's return on equity.

Company Net Margins Return on Equity Return on Assets
Synthomer-9.03% -16.66% -0.28%
Iofina 11.84%14.89%5.18%

Synthomer has a beta of 1.012, meaning that its share price is 1% more volatile than the broader market. Comparatively, Iofina has a beta of 0.53, meaning that its share price is 47% less volatile than the broader market.

Iofina has lower revenue, but higher earnings than Synthomer. Synthomer is trading at a lower price-to-earnings ratio than Iofina, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Synthomer£1.74B0.09-£82.04M-£96.00N/A
Iofina£66.52M1.53£4.28M£4.0013.25

19.7% of Synthomer shares are held by institutional investors. Comparatively, 1.5% of Iofina shares are held by institutional investors. 5.0% of Synthomer shares are held by insiders. Comparatively, 13.4% of Iofina shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Summary

Iofina beats Synthomer on 12 of the 16 factors compared between the two stocks.

How does Iofina compare to Hardide?

Hardide (LON:HDD) and Iofina (LON:IOF) are both small-cap basic materials companies, but which is the superior business? We will compare the two companies based on the strength of their media sentiment, risk, institutional ownership, earnings, profitability, dividends, valuation and analyst recommendations.

Iofina has a consensus target price of GBX 60, suggesting a potential upside of 13.21%. Given Iofina's stronger consensus rating and higher possible upside, analysts plainly believe Iofina is more favorable than Hardide.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Hardide
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Iofina
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00

Iofina has higher revenue and earnings than Hardide. Iofina is trading at a lower price-to-earnings ratio than Hardide, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Hardide£8.02M7.05-£1.89M£1.8039.82
Iofina£66.52M1.53£4.28M£4.0013.25

Hardide has a net margin of 15.60% compared to Iofina's net margin of 11.84%. Hardide's return on equity of 32.49% beat Iofina's return on equity.

Company Net Margins Return on Equity Return on Assets
Hardide15.60% 32.49% -9.80%
Iofina 11.84%14.89%5.18%

Hardide has a beta of 1.124, indicating that its share price is 12% more volatile than the broader market. Comparatively, Iofina has a beta of 0.53, indicating that its share price is 47% less volatile than the broader market.

In the previous week, Hardide had 2 more articles in the media than Iofina. MarketBeat recorded 3 mentions for Hardide and 1 mentions for Iofina. Hardide's average media sentiment score of 0.96 beat Iofina's score of 0.49 indicating that Hardide is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Hardide
2 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Iofina
0 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

10.2% of Hardide shares are owned by institutional investors. Comparatively, 1.5% of Iofina shares are owned by institutional investors. 65.7% of Hardide shares are owned by insiders. Comparatively, 13.4% of Iofina shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Summary

Hardide beats Iofina on 9 of the 16 factors compared between the two stocks.

Get Iofina News Delivered to You Automatically

Sign up to receive the latest news and ratings for IOF and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding IOF and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

IOF vs. The Competition

MetricIofinaSpecialty Chemicals IndustryMaterials SectorLON Exchange
Market Cap£101.69M£8.50B£4.74B£2.77B
Dividend Yield2.88%3.40%5.00%6.16%
P/E Ratio13.2514.8622.86366.30
Price / Sales1.53118.735,580.7886,092.70
Price / Cash7.9619.5727.0527.85
Price / Book2.363.368.817.90
Net Income£4.28M£213.62M£157.26M£5.89B
7 Day Performance4.54%-0.38%-3.18%-1.10%
1 Month Performance8.61%-0.84%-4.24%-0.89%
1 Year Performance108.66%24.39%51.70%68.85%

Iofina Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
IOF
Iofina
2.1927 of 5 stars
GBX 53
flat
GBX 60
+13.2%
+118.2%£101.69M£66.52M13.2595
ESNT
Essentra
3.2788 of 5 stars
GBX 85.20
+1.4%
GBX 150
+76.1%
-16.9%£235.37M£302M121.71350
ZTF
Zotefoams
4.068 of 5 stars
GBX 445.78
+2.6%
GBX 605
+35.7%
+32.0%£213.70M£158.49M9.93549
TET
Treatt
0.4964 of 5 stars
GBX 302
-0.2%
GBX 248.33
-17.8%
+18.3%£178.58M£128.29M41.83350
SYNT
Synthomer
1.6114 of 5 stars
GBX 115
+5.9%
GBX 86.75
-24.6%
-13.3%£178.04M£1.74BN/A4,200

Related Companies and Tools


This page (LON:IOF) was last updated on 6/24/2026 by MarketBeat.com Staff.
From Our Partners